Cargando…
Actual Persistence of Abatacept in Rheumatoid Arthritis: Results of the French-Ric Network
Objectives: Data on abatacept (ABA) persistence in routine practice are limited. We aimed to study ABA persistence rates at 12 months, according to the date of initiation, and to analyze the factors associated with persistence at 12 months. Methods: We performed an observational, ambispective, multi...
Autores principales: | Salmon, Jean-Hugues, Letarouilly, Jean-Guillaume, Goëb, Vincent, Kanagaratnam, Lukshe, Coquerelle, Pascal, Guyot, Marie-Hélène, Houvenagel, Eric, Lecuyer, Nicolas, Marguerie, Laurent, Morel, Gauthier, Baudens, Guy, Gervais, Elisabeth, Flipo, René-Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290911/ https://www.ncbi.nlm.nih.gov/pubmed/32438597 http://dx.doi.org/10.3390/jcm9051528 |
Ejemplares similares
-
Differential retention of adalimumab and etanercept biosimilars compared to originator treatments: Results of a retrospective French multicenter study
por: Larid, Guillaume, et al.
Publicado: (2022) -
Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study
por: Darloy, Jean, et al.
Publicado: (2019) -
Characteristics of Patients Treated with JAK Inhibitors in Rheumatoid Arthritis before versus after VTE Risk Warnings
por: Philippoteaux, Cécile, et al.
Publicado: (2022) -
Prognostic Factors Related to Clinical Response in 210 Knees Treated by Platelet-Rich Plasma for Osteoarthritis
por: Chopin, Clément, et al.
Publicado: (2023) -
Comparison of Rheumatoid Arthritis Patients’ 2-Year Infliximab, Abatacept, and Tocilizumab Persistence Rates
por: Diep, Laetitia, et al.
Publicado: (2022)